Faculty: Marion Munk, MD, Ph.D Faculty: David Boyer, MD This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

Faculty: Marion Munk, MD, Ph.D Faculty: Diana V. Do, MD This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

Faculty: Diana V. Do, MD Faculty: Marion Munk, MD, Ph.D This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

Faculty: David Boyer, MD Faculty: Marion Munk, MD, Ph.D This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

Faculty: Marion Munk, MD, Ph.D Faculty: David Boyer, MD This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.

Hope Psychology for Educators: Why It Matters More Than Ever

Host: Hallie Blevins, PhD. Early resistance to hydroxyurea in patients with polycythemia vera (PV) is associated with higher risks of thromboembolic complications, disease progression, and mortality. The PV-AIM study applied machine learning to real-world data and identified simple lab-based predictors that stratify patients by risk, and these findings were later validated in the HU-F-AIM trial. Hear from ReachMD's Dr. Hallie Blevins as she dives into the results and explains

Morgane Boillot chats with Professor Shiv Saidha (Johns Hopkins University, USA) about recent developments in diagnosing multiple sclerosis, and specifically on the use of paraclinical tests of the optic nerve in this context.

24 - Nine species of moa, giant flightless birds, once dominated every part of New Zealand. What effect did their rapid extinction just 500-600 years ago have and how is their loss still affecting rewilding ecosystems today? And - can we really bring them back? Join me, Maureen Howard to find out, as I chat with my guest Quinn Berentson, author of The Moa: The Life and Death of New Zealand’s Legendary Bird. This episode of Rewilding in Action is supported by Bin Inn Dunedin. For more information go

Show notes at pharmacyjoe.com/episode1060. In this episode, I'll discuss aiming for high-normal potassium to reduce sustained ventricular tachycardia in patients with an ICD.The post 1060: Aiming for high-normal potassium to reduce VTach in patients with an ICD appeared first on Pharmacy Joe.

Episode Summary:In this special episode, Solar Maverick Podcast co-host Li Wang turns the microphone on Benoy Thanjan, who shares his experience as a 9/11 survivor and how that day changed the course of his life. Benoy recounts being inside the World Trade Center when the first plane hit, the chaos of escaping, and the lasting impact of witnessing tragedy up close. He opens up about gratitude, resilience, and how the experience pushed him to pursue work that makes a difference. Key Takeaways Living

It is time to revisit this episode is all about the passion flower family - Passifloraceae. Joining us is long time friend of the podcast, the one and only Rebecca Hilgenhof. Rebecca is extremely passionate about this group and I can't think of a better person to dish out an eloquent introduction to these wonderful plants. This episode was produced in part by Yellowroot, Wisewren, Nadia, Heidi, Blake, Josh, Laure, R.J., Carly, Lucia, Dana, Sarah, Lauren, Strych Mind, Linda, Sylvan, Austin, Sarah,

My guest in this episode is Brandon Rice. Brandon is the CEO and co-founder at Weave Bio, a software company focused on automating regulatory submissions in the pharmaceutical industry using AI where he oversees product development, specifically leading the creation of AutoIND, their AI-powered platform for IND preparation.   In this conversation, Brandon discusses his journey to co-founding Weave Bio. He highlights the challenges of regulatory compliance, the potential of AI to streamline

ESS et al Music 'Shotgun Loudmouth' By Battery Life

Series authorsdiscuss their papers on artificial intelligence and infectious diseases intended to support the infectious diseases community in understanding this evolving landscape.

Eye On The Night Sky For Tuesday, September 16

Humanism in an Aging Society: Embracing Meaning and Personal Growth

Host: Ryan Quigley In relapsed or refractory follicular lymphoma, disease control is only part of the equation. In this AudioAbstract, ReachMD's Ryan Quigley explores patient-reported outcomes from the ELM-2 trial, revealing that odronextamab not only delivers high response rates but also helps preserve—and in some cases, improve—quality of life.

Juan Carlos Bazo Alvarez and Claudia Cooper join us to discussantipsychotic prescriptions in people with dementia in primary care.

Climate Matters is an audio version of Resilienz Ltd's Climate Matters newsletter, that gives intriguing insights into climate breakdown and climate recovery.